Semler Scientific (OTCMKTS:SMLR) and SONOVA Hldg AG/ADR (OTCMKTS:SONVY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.
This is a summary of current recommendations for Semler Scientific and SONOVA Hldg AG/ADR, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|SONOVA Hldg AG/ADR||0||0||0||0||N/A|
Semler Scientific presently has a consensus price target of $44.00, indicating a potential upside of 44.78%. Given Semler Scientific’s higher possible upside, equities analysts plainly believe Semler Scientific is more favorable than SONOVA Hldg AG/ADR.
SONOVA Hldg AG/ADR pays an annual dividend of $0.30 per share and has a dividend yield of 0.9%. Semler Scientific does not pay a dividend. SONOVA Hldg AG/ADR pays out 22.9% of its earnings in the form of a dividend.
Insider & Institutional Ownership
9.7% of Semler Scientific shares are owned by institutional investors. Comparatively, 0.2% of SONOVA Hldg AG/ADR shares are owned by institutional investors. 13.9% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This table compares Semler Scientific and SONOVA Hldg AG/ADR’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|SONOVA Hldg AG/ADR||N/A||N/A||N/A|
Risk and Volatility
Semler Scientific has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, SONOVA Hldg AG/ADR has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.
Valuation & Earnings
This table compares Semler Scientific and SONOVA Hldg AG/ADR’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Semler Scientific||$12.45 million||15.43||-$1.51 million||($0.28)||-108.54|
|SONOVA Hldg AG/ADR||$2.73 billion||3.92||$412.45 million||$1.31||24.92|
SONOVA Hldg AG/ADR has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than SONOVA Hldg AG/ADR, indicating that it is currently the more affordable of the two stocks.
Semler Scientific beats SONOVA Hldg AG/ADR on 8 of the 15 factors compared between the two stocks.
Semler Scientific Company Profile
Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform to evaluate patients with various chronic diseases. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is headquartered in San Jose, California.
SONOVA Hldg AG/ADR Company Profile
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name. Sonova Holding offers its products through a sales and distribution network, which comprise approximately 50 Sonova-owned wholesale companies and 100 independent distributors; and AudioNova retail network of approximately 3,300 locations in 12 markets. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.